RNU6-104P

Across TCGA pan-cancer cohorts, RNU6-104P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-104P data layer compared with 3 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-104P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-104P expression acts as an unfavorable survival marker.

KIRC, COAD, and THCA are the cancer types where RNU6-104P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.077	0.755	<.001	78	view →
COAD	DFS	Tertile	All	0.171	0.797	<.001	63	view →
THCA	OS	Tertile	All	0.819	0.983	<.001	60	view →
THYM	OS	Tertile	All	0.534	0.968	<.001	54	view →
SARC	OS	Tertile	All	0.151	0.730	.004	24	view →
GBM	DFS	Tertile	All	0.048	0.257	.001	18	view →
SKCM	DFS	Tertile	III,IV	0.053	0.648	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-104P–KIRC (DFS)

Open the KIRC breakdown →